NDC11 70594004902
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70594-0049-02 | 70594-0049 |
| 70594-0049-2 | 70594-0049 |
| 70594-049-02 | 70594-049 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Polymyxin B | POLYMYXIN B SULFATE | Xellia Pharmaceuticals USA LLC | b56f18c0-ef5e-4ed9-a5af-f79f3cd189b6 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | 70594-049-02 70594-049 70594004902 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.